- Happy Head
- Hims and Hers
- Apostrophe: dermatology-focused telehealth company acquired by Hims in 2021. Finasteride information page
- Keeps, owned by Thirty Madison
- Lemonaid Health
- Strut Health
Brown, Kristen V., and Gerrit De Vynck. Hims built a $1.6 billion online empire by pushing prescriptions. Bloomberg Prognosis. October 30, 2020.
Brown, Kristen V., and Gerrit De Vynck. Startups are hawking Zoloft and beta-blockers for off-label uses. Bloomberg Prognosis. April 2, 2019.
Brown, Kristen V., Gerrit De Vynck, and Robert Langreth. Men are paying sixfold markups to feel cool about buying generic Viagra. Bloomberg Prognosis. May 22, 2019.
Gallagher, Jacob. Losing your hair? Why this solution is no longer shameful. Wall Street Journal. Feb 21, 2020.
Safdar, Khadeeja. Lawmakers call for oversight of telehealth ads promoting drugs. Wall Street Journal. January 19, 2023.
Safdar, Khadeeja. Misleading ads fueled rapid growth of online mental health companies. Wall Street Journal. December 27, 2022.
Winkler, Rolfe. ADHD specialists worry stimulant drugs are overprescribed, push for treatment guidelines. Wall Street Journal. September 1, 2022.
More articles on telehealth companies by Rolfe Winkler in the Wall Street Journal.
[⚠️ All authors have a relationship to telehealth company Keeps, as Medical Director, employee of parent company or medical advisor] Young PC, Mahajan C, Shapiro J, Tosti A. Digital health platforms expand access and improve care for male androgenetic alopecia. Int J Dermatol. 2023. doi:10.1111/ijd.16452 • PubMed